News & Updates
Filter by Specialty:

Nirmatrelvir-ritonavir benefits persist against COVID
Management of most adults with COVID-19, particularly those with mild-to-moderate disease, is increasingly occurring in the outpatient setting due to the availability of effective treatment options.
Nirmatrelvir-ritonavir benefits persist against COVID
07 Nov 2023
Cefazolin beneficial in infective endocarditis caused by methicillin-susceptible S aureus
In the treatment of patients with methicillin-susceptible S aureus (MSSA)-associated infective endocarditis, the cefazolin is as good as cloxacillin, with similar mortality and relapse rates, according to a study.
Cefazolin beneficial in infective endocarditis caused by methicillin-susceptible S aureus
06 Nov 2023
Histologic inflammation of IBD a risk factor for serious infections
Among individuals with inflammatory bowel disease (IBD), histologic inflammation appears to contribute to an increased risk of serious infections such as sepsis, according to a study, suggesting that achieving remission may reduce infections in IBD.
Histologic inflammation of IBD a risk factor for serious infections
03 Nov 2023
Antiviral therapy safe, effective in children with immune-tolerant HBV infection
Treatment with antiviral therapy is beneficial and generally tolerated in children with chronic hepatitis B virus (HBV) infection in the immune-tolerant stage, according to the results of a systematic review and meta-analysis.
Antiviral therapy safe, effective in children with immune-tolerant HBV infection
28 Oct 2023
One BPG dose may be enough to treat syphilis, regardless of HIV status
Three doses of benzathine penicillin G (BPG) are not necessarily better than a single dose in the treatment of early syphilis in individuals with or without HIV infection, as shown in a study.